RYE, NY – August 8, 2016 – Curemark and The Autism Society of America today announce their collaboration on key Autism Society of America initiatives focused on supporting the wellbeing of people with autism and maximizing their quality of life. Both organizations share a common goal; to help individuals with autism lead lives with greater self-determination and fulfillment.
Scott Badesch, President and CEO of the Autism Society explains, “In collaborating with Curemark, we believe we have an important and valued partner in advancing our mission.”
Dr. Joan Fallon, CEO of Curemark said that, “Autism is one of our core areas of focus and we are excited to support the important work of The Autism Society. The Autism Society of America and their affiliate network across the country are a trusted resource for families affected by autism. Through their grassroots and education efforts, they empower individuals and families to educate and advocate for themselves.”
Curemark, LLC is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of neurological disorders. Curemark’s pipeline includes preclinical and clinical-stage programs for the treatment of Autism, ADHD, addiction, Schizophrenia and Parkinson’s disease. For additional information, please visit http://www.curemark.com or follow @curemark on Twitter.
CM-AT, Curemark’s lead drug candidate, has been granted “Fast Track” designation by the U.S. Food and Drug Administration for the investigation of Autism. The company is currently enrolling a Phase III double blind, randomized, placebo-controlled clinical trial (known as the Blüm Study) to examine the effect of CM-AT in children ages 3-8 with Autism. The trial is enrolling in over 20 sites across the United States. For additional information, please see: http://www.blumstudy.com.
Founded in 1965, the Autism Society is the nation’s leading grassroots autism organization, and exists to improve the lives of all affected by autism. We do this by increasing public awareness about the day-to-day issues faced by people on the autism spectrum, advocating for appropriate services for individuals across the lifespan, and providing the latest information regarding treatment, education and research. The Society maintains a strong nationwide network of affiliates to provide support and grassroots advocacy at local, state and federal levels. www.autism-society.org.